Economic Trend Alert: India's Next Small Cap Wave
Here is the latest financial fact sheet of FABINO LIFE . For more details, see the FABINO LIFE quarterly results and FABINO LIFE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 5.0 |
No. of shares | m | 2.10 |
1 Week | % | 0.0 |
1 Month | % | -0.7 |
1 Year | % | - |
52 week H/L | Rs | 43.8/25.1 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
FABINO LIFE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | NA | NA | NA | 49 | 38 | |
Low | Rs | NA | NA | NA | 24 | 23 | |
Sales per share (Unadj.) | Rs | 184.1 | 501.1 | 25.5 | 20.0 | 16.0 | |
Earnings per share (Unadj.) | Rs | 0 | 4.6 | 0.3 | 0.2 | 0.1 | |
Diluted earnings per share | Rs | 0.0 | 0.3 | 0.1 | 0.2 | 0.1 | |
Cash flow per share (Unadj.) | Rs | 1.7 | 5.8 | 0.4 | 0.4 | 0.2 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 40.3 | 44.9 | 10.9 | 19.5 | 19.6 | |
Adj. book value per share | Rs | 2.9 | 3.2 | 6.2 | 19.5 | 19.6 | |
Shares outstanding (eoy) | m | 0.15 | 0.15 | 1.20 | 2.10 | 2.10 | |
Price / Sales ratio | x | 0 | 0 | 0 | 1.8 | 1.9 | |
Avg P/E ratio | x | 0 | 0 | 0 | 162.8 | 590.4 | |
P/CF ratio (eoy) | x | 0 | 0 | 0 | 97.8 | 149.3 | |
Price / Book Value ratio | x | 0 | 0 | 0 | 1.9 | 1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 0 | 0 | 0 | 76 | 63 | |
Total wages/salary | Rs m | 3 | 2 | 1 | 2 | 2 |
FABINO LIFE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 28 | 75 | 31 | 42 | 34 | |
Other income | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total revenues | Rs m | 28 | 75 | 31 | 42 | 34 | |
Gross profit | Rs m | 3 | 3 | 1 | 1 | 0 | |
Depreciation | Rs m | 0 | 0 | 0 | 0 | 0 | |
Interest | Rs m | 3 | 2 | 0 | 0 | 0 | |
Profit before tax | Rs m | 0 | 1 | 0 | 1 | 0 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | 0 | 1 | 0 | 0 | 0 | |
Gross profit margin | % | 11.6 | 4.2 | 2.1 | 2.1 | 1.0 | |
Effective tax rate | % | 106.7 | 30.5 | 28.9 | 28.6 | 10.8 | |
Net profit margin | % | 0 | 0.9 | 1.0 | 1.1 | 0.3 |
FABINO LIFE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 79 | 29 | 20 | 44 | 48 | |
Current liabilities | Rs m | 76 | 17 | 6 | 4 | 4 | |
Net working cap to sales | % | 9.1 | 16.3 | 47.9 | 94.0 | 128.8 | |
Current ratio | x | 1.0 | 1.7 | 3.6 | 10.6 | 10.7 | |
Inventory Days | Days | 77 | 28 | 8 | 7 | 8 | |
Debtors Days | Days | 3,382 | 1,130 | 158,535,822 | 124,821,816 | 274,533,512 | |
Net fixed assets | Rs m | 7 | 7 | 2 | 3 | 2 | |
Share capital | Rs m | 2 | 2 | 12 | 21 | 21 | |
"Free" reserves | Rs m | 5 | 5 | 1 | 20 | 20 | |
Net worth | Rs m | 6 | 7 | 13 | 41 | 41 | |
Long term debt | Rs m | 1 | 11 | 3 | 0 | 4 | |
Total assets | Rs m | 85 | 36 | 22 | 46 | 50 | |
Interest coverage | x | 1.0 | 1.5 | 7.0 | 11.8 | 1.9 | |
Debt to equity ratio | x | 0.2 | 1.6 | 0.2 | 0 | 0.1 | |
Sales to assets ratio | x | 0.3 | 2.1 | 1.4 | 0.9 | 0.7 | |
Return on assets | % | 3.4 | 7.6 | 1.6 | 1.1 | 0.5 | |
Return on equity | % | 0 | 10.2 | 2.3 | 1.1 | 0.3 | |
Return on capital | % | 39.6 | 17.2 | 3.0 | 1.7 | 0.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 0 | 0 | 0 | 0 | 0 | |
Net fx | Rs m | 0 | 0 | 0 | 0 | 0 |
FABINO LIFE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2 | 24 | -5 | -19 | -7 | |
From Investments | Rs m | -0 | -0 | -1 | -1 | -0 | |
From Financial Activity | Rs m | -2 | -24 | 4 | 25 | 3 | |
Net Cashflow | Rs m | 0 | 1 | -1 | 5 | -3 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Atul Kumar Jain | COMP SEC: Jeel Poshiya | YEAR OF INC: 2011 | BSE CODE: 543444 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare FABINO LIFE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Stocks in Asia opened broadly lower Friday as traders reassessed the path forward for interest rates, while equities in Hong Kong braced for further gains on bullish corporate results.